Projection of healthcare demand in Germany and Switzerland urged by Omicron wave (January–March 2022)

[1]  J. McCaw,et al.  Real-time analysis of hospital length of stay in a mixed SARS-CoV-2 Omicron and Delta epidemic in New South Wales, Australia , 2023, BMC Infectious Diseases.

[2]  O. Dyer.  Covid-19: China stops counting cases as models predict a million or more deaths , 2023, BMJ.

[3]  Quentin J. Leclerc,et al.  Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era , 2022, Nature Communications.

[4]  W. Haas,et al.  SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  S. Mayor.  Covid-19: Warning over transmission risk as self-isolation is cut to five days in England , 2022, BMJ.

[6]  M. Lipsitch,et al.  Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California , 2022, medRxiv.

[7]  N. Volkow,et al.  Comparison of outcomes from COVID infection in pediatric and adult patients before and after the emergence of Omicron , 2022, medRxiv.

[8]  B. Abdalhamid,et al.  Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster — Nebraska, November–December 2021 , 2021, MMWR. Morbidity and mortality weekly report.

[9]  K. Spiess,et al.  SARS-CoV-2 Omicron VOC Transmission in Danish Households , 2021, medRxiv.

[10]  B. Keijser,et al.  SIR model for assessing the impact of the advent of Omicron and mitigating measures on infection pressure and hospitalization needs , 2021, medRxiv.

[11]  J. Bhiman,et al.  Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa , 2021, medRxiv.

[12]  M. Kraemer,et al.  Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa , 2021, Nature.

[13]  S. Madhi,et al.  South African Population Immunity and Severe Covid-19 with Omicron Variant , 2021, medRxiv.

[14]  A. Sigal,et al.  Analysis: A meta-analysis of Early Results to predict Vaccine efficacy against Omicron , 2021, medRxiv.

[15]  P. Rheeder,et al.  Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa , 2021, International Journal of Infectious Diseases.

[16]  A. Azman,et al.  Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021 , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[17]  J. Starrfelt,et al.  No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway , 2021, International Journal of Infectious Diseases.

[18]  A. Azman,et al.  Seroprevalence of anti-SARS-CoV-2 antibodies six months into the vaccination campaign in Geneva, Switzerland , 2021, medRxiv.

[19]  Y. Liu,et al.  The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus , 2021, Journal of travel medicine.

[20]  E. Lorin,et al.  Distribution of incubation periods of COVID-19 in the Canadian context , 2021, Scientific Reports.

[21]  C. Althaus,et al.  A tale of two variants: Spread of SARS-CoV-2 variants Alpha in Geneva, Switzerland, and Beta in South Africa , 2021, medRxiv.

[22]  B. Rachet,et al.  Probabilities of ICU admission and hospital discharge according to patient characteristics in the designated COVID-19 hospital of Kuwait , 2020, BMC Public Health.

[23]  H. Gorji,et al.  Smart investment of virus RNA testing resources to enhance Covid-19 mitigation , 2020, medRxiv.

[24]  F. Balabdaoui,et al.  Age-stratified discrete compartment model of the COVID-19 epidemic with application to Switzerland , 2020, Scientific Reports.

[25]  Jakub Dolezal,et al.  Efficient Bayesian inference of fully stochastic epidemiological models with applications to COVID-19 , 2020, Royal Society Open Science.

[26]  Eric H. Y. Lau,et al.  Temporal dynamics in viral shedding and transmissibility of COVID-19 , 2020, Nature Medicine.

[27]  C. Whittaker,et al.  Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand , 2020 .

[28]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[29]  M. Jit,et al.  Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination , 2017, bioRxiv.

[30]  Mark Jit,et al.  Projecting social contact matrices in 152 countries using contact surveys and demographic data , 2017, PLoS Comput. Biol..

[31]  V. Isham,et al.  Five challenges for spatial epidemic models , 2015, Epidemics.

[32]  Zhilan Feng,et al.  Social contact patterns and control strategies for influenza in the elderly. , 2012, Mathematical biosciences.

[33]  Alessandro Vespignani,et al.  Inferring the Structure of Social Contacts from Demographic Data in the Analysis of Infectious Diseases Spread , 2012, PLoS Comput. Biol..

[34]  O Diekmann,et al.  The construction of next-generation matrices for compartmental epidemic models , 2010, Journal of The Royal Society Interface.

[35]  J. Arino,et al.  A multi-city epidemic model , 2003 .

[36]  W. Hinsley,et al.  Report 50: Hospitalisation risk for Omicron cases in England , 2021 .

[37]  D. Français,et al.  Federal Office of Public Health FOPH , 2013 .

[38]  Carl A. B. Pearson,et al.  Modelling the potential consequences of the Omicron SARS-CoV-2 variant in England , 2022 .